Why it was recalled
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Product description
BroveX PSE, Antihistamine, Nasal Decongestant, 100 count bottle, OTC, Manufactured for: Pernix Therapeutics, Gonzales, LA 70737 NDC 58605-440-01
Lot numbers, UPCs & expiration codes
Lot# 11A001 Exp. 12/12; Lot# 11L002 Exp. 10/13; Lot # 12K007 Exp. 09/14.
Where it was sold
FL, MS, SC, LA and TX
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-524-2013
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Jan 30, 2013
- FDA report date
- Jun 12, 2013
- Quantity
- 10,036 bottles - 100-count tablets
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- TG United, Inc.
Original FDA data
Every field from FDA enforcement report D-524-2013, exactly as published.
Show all FDA fields
- City
- Brooksville
- State
- FL
- Status
- Terminated
- Country
- United States
- Event ID
- 64188
- Address
- 16275 Aviation Loop Dr
- Code information
- Lot# 11A001 Exp. 12/12; Lot# 11L002 Exp. 10/13; Lot # 12K007 Exp. 09/14.
- Postal code
- 34604-6805
- Report date
- Jun 12, 2013
- Product type
- Drugs
- Recall number
- D-524-2013
- Classification
- Class II
- Recalling firm
- TG United, Inc.
- Product quantity
- 10,036 bottles - 100-count tablets
- Termination date
- Sep 30, 2016
- Reason for recall
- CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- BroveX PSE, Antihistamine, Nasal Decongestant, 100 count bottle, OTC, Manufactured for: Pernix Therapeutics, Gonzales, LA 70737 NDC 58605-440-01
- Distribution pattern
- FL, MS, SC, LA and TX
- Recall initiation date
- Jan 30, 2013
- Initial firm notification
- Letter
- Center classification date
- Jun 4, 2013